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CC BY-NC-ND license (http://creativeAbstract The bHLH transcription factor Twist1 has emerged as a negative regulator of chon-
drogenesis in skeletal progenitor cells and as an inhibitor of maturation in growth plate chon-
drocytes. However, its role in articular cartilage remains obscure. Here we examine Twist1
expression during re-differentiation of expanded human articular chondrocytes, the distribu-
tion of Twist1 proteins in normal versus OA human articular cartilage, and its role in modu-
lating OA development in mice. High levels of Twist1 transcripts were detected by qPCR
analyses of expanded de-differentiated human articular chondrocytes that had acquired
mesenchymal-like features. The induction of hallmark cartilage genes by Bmp-2 mediated
chondrogenic differentiation was paralleled by the dramatic suppression of Twist1 in vitro.
In normal human articular cartilage, Twist1-expressing chondrocytes were most abundant in
the superficial zone with little to no expression in the middle and deep zones. However, our
analyses revealed a higher proportion of deep zone articular chondrocytes expressing Twist1
in human OA cartilage as compared to normal articular cartilage. Moreover, Twist1 expression
was prominent within proliferative cell clusters near fissure sites in more severely affected OA
samples. To assess the role of Twist1 in OA pathophysiology, we subjected wild type mice and
transgenic mice with gain of Twist1 function in cartilage to surgical destabilization of the
medial meniscus. At 12 weeks post-surgery, micro-CT and histological analyses revealed atten-
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Osteoarthritis (OA), the most common form of arthritis in
middle aged and older individuals, is characterized by the
progressive degeneration of articular cartilage, joint space
narrowing, subchondral bone sclerosis, and the formation
of bony outgrowths at the joint margins.1 During the
development of OA, the articular chondrocytes undergo
distinct phenotypic changes, including the activation of
hypertrophy and maturation, aberrant induction of carti-
lage matrix degrading enzymes, and cell death.2,3 The
signaling pathways and molecular mechanisms that play an
essential role in maintaining chondrocyte homeostasis and
integrity of the hyaline cartilage matrix are becoming
increasingly better understood. Aberrant signaling through
developmental pathways controlling chondrocyte differ-
entiation, such as the transforming growth factor-beta
(TGF-b) pathway and the wingless MMTV integration (Wnt)
pathway, are recognized as key contributing factors to the
progressive degeneration of articular cartilage in OA (1e5).
Thus, functional characterization of the common tran-
scriptional regulators downstream of these fundamental
signaling pathways may offer new insights into the patho-
physiology of OA. In this regard, we previously identified
the transcription factor Twist1 as a negative regulator of
chondrocyte progression toward hypertrophy and terminal
maturation in response to TGF-b and canonical Wnt
signals.4
Twist1 is an evolutionarily conserved basic helix loop
helix (bHLH) transcription factor that exerts pleiotropic
effects as a mesoderm-determining factor, an epithelial-
mesenchymal transitional regulator, and a critical regulator
of the gene regulatory network in mesenchymal cell lineage
allocation during skeletal development.5e13 Expression of
Twist1 is abundant throughout the condensed mesenchyme
that gives rise to both chondrocytes and osteoblasts of the
vertebrate skeleton.6 In humans, haploinsufficiency of
Twist1 results in an autosomal dominant inherited disorderSaethre-Chotzen syndrome, characterized by craniosynos-
tosis, short stature, and craniofacial defects.14 Moreover,
several genetic studies examining the role of Twist1 in limb
development previously demonstrated the requirement for
Twist1 in mediating the outgrowth and patterning of the
limb via modulation of the fibroblast growth factor (FGF)
and sonic hedgehog (SHH) signaling pathways.8,15e18 Kraw-
chuk et al further demonstrated significant forelimb
patterning defects, tibial aplasia, and highly disorganized
cartilage elements in mice with inactivation of Twist1 in
Prx1-expressing mesenchyme.8 Collectively, these studies
have provided substantial evidence of the requirement for
Twist1 activity in defining multiple functions during limb
development.
Through a combination of functional and mechanistic
studies we, and others, previously examined the specific
role of Twist1 in chondrogenesis and chondrocyte matura-
tion.4,19,20 Using chondrocyte precursor cells, Reinhold et al
demonstrated that Twist1 functions as a potent inhibitor of
chondrogenesis19 and the suppressive effects of Twist1 are
mediated, in part, through binding of the carboxyl-terminal
Twist box to the DNA-binding domain of the master chon-
drogenic factor Sox9.19 Importantly, this direct physical
interaction led to inhibition of Sox9-dependent activation
of chondrocyte marker gene expression.19,21 Association of
Twist1 to the 30UTR of Sox9 has also been found to nega-
tively regulate the chondrogenic initiation program in
skeletogenic and mesenchymal murine cell lines.22 We
previously determined that Twist1 expression is maintained
in the proliferating, immature chondrocytes of the post-
natal growth plate, whereas its expression is repressed in
hypertrophic chondrocytes both in vitro and in vivo.4,23
Bialek et al had previously demonstrated that the direct
interaction between Twist box with the DNA-binding
domain of the transcriptional factor Runx2 led to inhibi-
tion of Runx2 transcriptional activity.6 Using in vitro models
of chondrocyte maturation, we demonstrated that Twist1
acts as a potent repressor of hypertrophy in growth plate
chondrocytes downstream of TGF-beta and canonical Wnt
signaling4 and speculated that the inhibition of chondrocyte
maturation is mediated through its repressive effects on
Runx2, the master regulator of chondrocyte hypertrophy.24
Thus, through its interaction with transcriptional regula-
tors, Twist1 has the ability to regulate not only its direct
targets, but also other transcription factor-mediated gene
expression pathways involved in cartilage development and
maturation. When we generated Twist1 transgenic (TG)
mice with persistent expression in growth plate chon-
drocytes (Col2a1 expressing cells and progeny), we
observed abnormal growth plate organization and postnatal
longitudinal growth retardation attributed to impaired
endochondral ossification.23 While these collective studies
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growth of cartilage structures, the role of Twist1 in normal
maintenance and homeostasis of adult cartilage has
remained elusive.
Transcriptional analyses of healthy and OA human
articular cartilage from age-matched donors revealed the
significant elevation of Twist1 transcript levels in OA
compared to normal articular cartilage.25 However, no
further analyses were performed to examine the expression
and distribution of Twist1 proteins in normal versus OA
human cartilage. In view of the inhibitory role of Twist1 in
mediating the developmental progression of chondrocytes
toward hypertrophy and terminal maturation, we specu-
lated that aberrant regulation of Twist1 may contribute to
some of the pathology-induced changes that arise in
articular chondrocytes during the onset and progression of
OA. In the present study, we examined whether Twist1
transcripts are regulated during the re-differentiation of
expanded human articular chondrocytes in vitro. By
immunolocalization, we further investigated the distribu-
tion of Twist1 proteins across the different zones of normal
human articular cartilage, and determined whether the
distribution of Twist1 proteins is altered in human OA
cartilage. To evaluate the in vivo function of Twist1 in
articular cartilage, we employed a well-established condi-
tional Cre/Lox strategy for cartilage-specific gain of func-
tion in mice (23). Using this genetic model, we further
explored whether elevated levels of Twist1 in cartilage al-
ters the severity of surgery induced OA in mice.Material and methods
Procurement of healthy donor and osteoarthritic
human osteochondral tissue
We obtained macroscopically normal femoral hemi-
condyles isolated from three male deceased, de-identified
human donors from the Musculoskeletal Transplant Foun-
dation (MTF). Donors (ages 27, 48, and 52 years) had no
history of joint disease. Osteochondral surgical discards
were obtained from three male patients (64, 70, and 72
years of age) with end-stage OA undergoing knee replace-
ment surgery at our clinic, in accordance with protocol
approval by the UConn Health Institutional Review Board
(IRB). Three to four cartilage-bone cylinders (6  6 mm) per
sample were punched out perpendicular to the articular
cartilage surface using an osteochondral delivery device
(Arthrex).Histologic and immunohistochemical analyses
Human osteochondral specimens were fixed in 10% formalin
and decalcified in EDTA prior to paraffin embedding as we
previously reported.23,26 Microtome sections (5um) were
deparaffinized in xylene, rehydrated through graded
ethanol, and stained with 1% Alcian Blue or Safranin O/Fast
Green (SO/FG). Immunohistochemical staining was per-
formed following routine methods for antibodies against
Twist1, Sox9, PCNA and VEGF.23 Image analysis was per-
formed using NIS-Elements BR 3.0 (Nikon, Melville, NY).Primary human articular chondrocyte culture and
re-differentiation
Normal human articular chondrocytes (NHAC-kn, #CC-
2250) were obtained from Lonza (Walkersville Inc).27 The
cells were cultured in monolayer at 37 C in a humidified
atmosphere with 5% CO2 in chondrocyte growth media
consisting of DMEM/F12 supplemented with 10% FBS,
25ug/mL ascorbic acid and 1% penicillin/streptomycin
solution. NHAC-kn cells (2.5  105 cells) were sedimented
(300  g, 5 min) in polypropylene tubes to generated high-
density pellets. Re-differentiation was induced by
culturing the pellets in serum-free media consisting of
DMEM-HG media (Gibco) supplemented with 1% ITSþ pre-
mix (containing human recombinant insulin, human
transferrin, seleneous acid, BSA and linoleic acid) (BD
Biosciences), 40 mg/mL L-proline, 1 mM sodium pyruvate,
1% non-essential amino acids, 2 mM Glutamax, 50 mg/mL
ascorbic acid 2-phosphate, 107 M dexamethasone, peni-
cillin/streptomycin and 100 ng/mL human recombinant
BMP-2 (Medtronic).27,28 Media and growth factor were
replenished every other day for up to 21 days of
differentiation.
Flow cytometric analysis
NHAC-kn cells (passage 5) were grown to near conflu-
ence, harvested by 0.25% trypsin/EDTA, washed with PBS
and re-suspended in staining solution consisting of 2% FBS
and 2% HEPES in PBS. Cell suspensions (1  106 cells)
were mixed with PE mouse anti-human CD90 (BD Phar-
mingen), PE mouse anti-human CD73 (BD Pharmingen), PE
mouse anti-human CD29 (BD Pharmingen), PE mouse anti-
human HLA-DR (BD Pharmingen), FITC mouse anti-human
CD44 (BD Pharmingen), FITC mouse anti-human HLA-ABC
(BD Pharmingen), FITC mouse anti-human CD105 (BD
Pharmingen), FITC mouse anti-human CD45 (BD Phar-
mingen), and FITC mouse anti-human CD31 (BD Phar-
mingen).28 Nonspecific fluorescence was determined by
incubation of cell aliquots with isotype-matched mono-
clonal antibodies (IgG1-PE and IgG2b-FITC). Samples were
run on a BectoneDickinson LSR II Flow Cytometer (BD
Biosciences) instrument using FACS Diva software (Becton
Dickinson). For each analysis, a minimum of 10,000 cells
was assayed. Data was analyzed using FloJo Software
(Tree Star, Inc.).
Gene expression analyses
Total RNA was extracted from undifferentiated and differ-
entiating NHAC cell cultures with TRIzol reagent (Invi-
trogen). RNA concentrations were determined by
measuring the absorbance at 260 nm. Samples of 1 mg were
treated with DNaseI (Biorad) to eliminate contamination
with genomic DNA, then reverse transcribed to single
stranded cDNA using iScript Reverse Transcriptase (Qiagen).
20 ng of cDNA was used for quantitative PCR analyses.
Quantitative PCR was performed using SYBR Green I Mas-
termix (Roche) and analyzed using a 7600 real time qPCR
machine (Applied Biosystems). Gene expression values are
expressed as 2^DeltaDeltaCt, with DeltaDeltaCt defined as
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undifferentiated and differentiated NHAC samples, using
Gapdh as an internal standard. Oligonucleotide primer se-
quences were as previously described in.28Surgical-induced osteoarthritis in mice
Female CAGCAT-Twist1 mice were bred with Col2a1-Cre
males to generate offspring heterozygous for each trans-
gene.23 Genotyping for the Twist1 and Cre transgenes were
performed by PCR analyses of genomic DNA isolated from
tail clips.23 Animal procedures were conducted according to
protocols approved by the Institutional Animal Care and Use
Committee (IACUC) at Maine Medical Center Research
Institute. We performed surgical destabilization of the
medial meniscus (DMM) as described by Kamekura et al29 to
model the development of OA in wild type and Twist1
transgenic mice. DMM surgeries were performed on skele-
tally mature, 10 week old mice, in accordance with our
approved animal protocol. A 5 mm incision was made on the
medial aspect of the knee joint and the medial collateral
ligament was divided to expose the medial compartment of
the joint. Attachment of the medial meniscus to the tibia
was transected to destabilize the medial meniscus without
damaging the underlying articular cartilage. Technically
proficient surgery resulted in excessive opening of the
medial side of the knee joint when stressed manually. Post-
operatively, animals were allowed immediate unrestricted
weight bearing. Mice were sacrificed at 12 weeks post-
surgery.Histological scoring of OA severity in mice
We employed the modified Chambers scoring system for
histologic scoring of murine OA joints at 12 weeks post-
DMM surgery.30 Proteoglycans were stained using Alcian
blue. A 0e6 subjective scoring system was applied to all
four quadrants of the joint: medial femoral condyle (MFC),
medial tibial plateau (MTP), lateral femoral condyle (LFC),
and lateral tibial plateau (LTP). A score of 0 represents
normal cartilage, 0.5 Z loss of PG with an intact surface,
1 Z superficial fibrillation without loss of cartilage,
2 Z vertical clefts and loss of surface lamina (any % or
joint surface area), 3 Z vertical clefts/erosion to the
calcified layer lesion for 1e25% of the quadrant width,
4 Z lesion reaches the calcified cartilage for 25e50% of
the quadrant width, 5 Z lesion reaches the calcified
cartilage for 50e75% of the quadrant width, 6 Z lesion
reaches the calcified cartilage for >75% of the quadrant
width. OA severity for wild type and Col2-Twist1 trans-
genic mice is expressed as individual scores for each joint
quadrant.Statistical analyses
Experiments were repeated using a minimum of three bio-
logical replicates per condition. Data are presented as
mean of three separate experiments  standard error. For
all tests, p < 0.05 was considered significant.Results
Expression of Twist1 is inversely correlated with
chondrogenic marker expression in differentiating
human articular chondrocytes
We initially assessed the relative levels of Twist1 transcripts
in mesenchymal-like cells that arise from de-differentiation
of human adult articular chondrocytes, and in cells re-
differentiated to the chondrocyte phenotype. The expan-
sion of human articular chondrocytes (hACs) following
multiple passages (p5-6) in monolayer culture led to the
acquisition of a characteristic fibroblast-like morphology
(data not shown), consistent with previous reports in the
literature.31e33 Flow cytometric analyses of cell surface
immunologic markers confirmed the mesenchymal
progenitor-like properties of the de-differentiated cells. As
shown in Fig. 1A, the hACs expressed cell surface antigens
indicative of a mesenchymal-like phenotype, including
CD29 (99.4%) CD44 (84%), CD73 (99.9%), CD90 (70.6%),
CD105 (80%), CD166 (92.2%) and HLA-ABC (81.6%). In
contrast, the cells lacked expression of the definitive he-
matopoietic lineage marker CD45 (7.9%), the endothelial
marker CD31 (8.8%), as well as the MHC class II cell surface
receptor HLA-DR (2.2%).
We next used the well-established human articular
chondrocyte pellet culture system in order to assess
whether Twist1 transcript levels are altered during differ-
entiation to a mature chondrocyte phenotype. Following
induction of chondrogenic differentiation by high-density
culture and treatment with human recombinant Bmp-2 for
three weeks, the cells produced a proteoglycan-rich matrix
that was visualized by Alcian blue staining of pellets
(Fig. 1B). Microscopic analyses further revealed morpho-
logical features of a mixed population of immature chon-
drocytes and hypertrophic chondrocytes within the central
core of the pellets (Fig. 1B). By quantitative PCR analyses,
the de-differentiated hACs exhibited a low level of
expression of hallmarks of the chondrocyte phenotype,
including cartilage transcription factors (Sox9, Runx2) and
cartilage matrix components (collagens types II, IX and X)
(Fig. 1C). By five days of differentiation, the master chon-
drogenic transcription factor Sox9 was significantly up-
regulated in Bmp-2 treated hAC pellets. This induction
was followed by increased transcript expression of the
chondrocyte hypertrophy marker Runx2 (Fig. 1C), reflecting
the progression toward a more differentiated chondrocyte
phenotype. Quantitative PCR analyses further revealed a
significant induction in the expression of cartilage matrix
genes Col2a1 and Col9a1 over the three-week differentia-
tion assay (Fig. 1C). Consistent with the histological fea-
tures of hypertrophic chondrocytes, the pellet culture
conditions promoted expressions of ColXa1 transcript be-
tween days 14 and 21 of differentiation (Fig. 1C). In
contrast, Twist1 transcript levels were highest in the de-
differentiated, mesenchymal-like articular chondrocyte
population, and were dramatically down-regulated by five
days of chondrogenic differentiation. This repression was
sustained at later time points (days 14e21), as the cells
acquired a more mature phenotype. Similar results were
obtained when hAC pellets were treated with TGFb1 to
Fig. 1 Expression of Twist1 is repressed in differentiating human articular chondrocytes. (A) De-differentiated normal human
articular chondrocytes (monolayer passage 5) exhibited features of mesenchymal-like progenitor cells. Cell surface flow cytometric
analyses of the proportion of dedifferentiated human articular chondrocytes expressing CD29, CD44, CD73, CD90, CD105, CD166,
HLA-ABC, HLA-DR, CD31, and CD45 receptors. IgG1 antibodies were included as a negative control. (B) Alcian blue staining of
human articular chondrocyte pellets cultured in serum-free media and in the presence of Bmp-2 for 21 days. Higher magnification
images in (ii) and (iii) revealed a heterogeneous population of immature and hypertrophic chondrocytes, respectively. Scale bar,
100 um. (C) RT-PCR-based gene expression analyses of Twist1 and chondrogenic markers Sox9, Runx2, Col2a1, Col9a1 and ColXa1 in
normal human articular chondrocyte pellets treated with Bmp-2 for 5, 8, 14, and 21 days in culture. The relative mRNA level in each
sample is normalized to its Gapdh content. The expression of Twist1 was suppressed as cells acquired a more differentiated
chondrocyte phenotype. *p < 0.05. Abbreviations: D0 refers to the undifferentiated population on day 0 prior to onset of
differentiation.
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(data not shown). Together, these data indicate that the
expression of Twist1 is negatively correlated with the
induced expressions of chondrogenic markers during re-
differentiation of human articular chondrocytes.Twist1 exhibits differential distribution in normal
versus osteoarthritic human articular cartilage
Our studies previously demonstrated that the expression of
Twist1 proteins was restricted to immature, proliferating
chondrocytes of the postnatal murine growth plate,
whereas little to no expression was observed in chon-
drocytes undergoing terminal maturation.23 However, no
prior studies have evaluated the spatial distribution of
Twist1 in normal versus OA human articular cartilage. Thus,we performed IHC analyses to assess the distribution of
Twist1 proteins across the discrete cartilage zones in
intact, full-thickness articular cartilage isolated from the
knee joints of three healthy male donors (ages 26, 48, and
52 years). Alcian blue staining of full thickness normal
human articular cartilage of the femoral condyle revealed
robust proteoglycan staining as well as the typical organi-
zation of articular chondrocytes across the superficial,
middle, and deep zones (Fig. 2A). Scoring of these human
donor condyles revealed no histological evidence of OA
pathology (average Mankin score 0.48). IHC analyses using
Twist1-specific antibodies showed presence of Twist1 pro-
teins within the flattened articular chondrocytes of the
superficial zone as well as some of the rounded chon-
drocytes within the middle zone of normal human articular
cartilage (Fig. 2B). Semi-quantitative assessments shown in
Fig. 2C showed enrichment of Twist1-expressing articular
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thickness cartilage). The vast majority of the flattened,
articular chondrocytes within the SZ exhibited Twist1Fig. 2 The zonal distribution of Twist1 proteins is altered in hu
and OA human articular cartilage. Discrete zones in normal articular
deep zone. OA cartilage exhibited diminished Alcian blue staining
Scale barZ 50 um (B) Representative images of Twist1 protein dist
chondrocytes in normal (i-iii) and OA (iv-vi) human articular cartil
localization within the nucleus of superficial zone articular chondr
staining was detected within the deep zone chondrocytes in norm
Assessment of the percentage of Twist1 positive cells detected via
deep zones of normal and OA human articular cartilage. A significan
Twist1 nuclear staining was detected in OA cartilage.immunostaining (85%  5.13%). By contrast, significantly
fewer Twist1 immune-positive chondrocytes were observed
within the rounded cells present in the middle zone (MZ) ofman OA articular cartilage. (A) Alcian blue staining of normal
cartilage are shown. SZ, superficial zone; MZ, middle zone; DZ,
and histological evidence of cartilage degeneration (arrow).
ribution across the superficial, middle and deep zone articular
age. Immunostaining using Twist1-specific antibodies revealed
ocytes (i, iv) in both normal and OA cartilage. Minimal Twist1
al human articular chondrocytes (iii). Scale bar Z 50 um (C)
Twist1-specific nuclear staining in the superficial, middle and
t increase in the number of deep zone chondrocytes exhibiting
Fig. 3 Activation of Twist1 expression in cartilage cell
clusters in OA cartilage. (A) Alcian blue staining shows pres-
ence hallmark cartilage cell cluster formation in severely
affected human OA cartilage (Mankin score >5). (B) Repre-
sentative images of Twist1-specific immunostaining in the OA
cartilage cell clusters. Cells within the clusters were also
positive for Sox9, VEGF, and PCNA. Scale bar Z 50 um (C)
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shown in Fig. 2C, the frequency of Twist1 positive cells was
significantly lower in deep zone (DZ) articular chon-
drocytes, with only 25.1%  1.36% of deep zone cells dis-
playing nuclear Twist1 expression.
Next we performed immunohistochemical analyses to
determine whether degeneration of human articular
cartilage was associated with changes in the normal dis-
tribution of Twist1 proteins. For these experiments, we
assessed Twist1 distribution across the cartilage layers in
mildly eroded OA human specimens (lateral femoral con-
dyles) in order to score a sufficient number of cells from
the presumptive superficial zone. Articular cartilage tissue
from OA specimens (male patients, ages 53, 64, and 72
years) displayed loss of proteoglycan staining, indicative of
cartilage erosion (Fig. 2A). These patient-derived OA
samples attained significantly higher histological grades of
OA (Mankin score 2.3) as compared to the healthy donor
control specimens (Mankin score 0.48). In OA cartilage,
some articular chondrocytes exhibited a strong Twist1
immune signal, and variable distribution across the
discrete zones. The frequency of Twist1 staining in OA
chondrocytes was highest in the SZ (86.4%  2.68%), and
the percentage of SZ cells expressing Twist1 was similar to
normal cartilage (Fig. 2C). The frequency of Twist1 nuclear
staining in middle zone chondrocytes was also similar be-
tween normal and mild OA-affected articular cartilage
(Fig. 2C). In contrast, there was a significant increase in
the percentage of deep zone chondrocytes exhibiting
Twist1 nuclear staining (50.4%  10.1%) in OA articular
compared to normal articular cartilage (25.0%  1.36%)
(Fig. 2C).
Activation of Twist1 expression in OA cartilage cell
clusters
The distribution of Twist1 proteins was further examined in
human patient cartilage surgical discards displaying a more
severe OA phenotype. As shown in Fig. 3A, there was
extensive loss of Alcian blue staining, as well as the
extensive appearance of fissures within the articular
cartilage of OA affected medial femoral condyles (Mankin
score >5). The pathology-induced cartilage changes was
further reflected by the presence of cell clusters, typically
near fissures or clefts34 in the severely affected human OA
samples (Fig. 3). By immunohistochemical staining, we
detected expression of Sox9 within the nuclei of the
cartilage cell clusters as well as pathology-induced staining
for vascular endothelial growth factor (VEGF) (Fig. 3).
Furthermore, the cartilage cell clusters in OA-affected
articular cartilage showed positive staining for the prolif-
erating cell nuclear antigen (PCNA), suggestive of cartilage
cell turnover and proliferation (Fig. 3). Nuclear Twist1
expression within the OA cluster cells (Fig. 2) was indicative
of its abnormal activation during OA pathology.
Immunohistochemical analyses of Twist1
expression in the murine adult joint
Our previous studies revealed the localization of Twist1
within the proliferating chondrocytes in the postnatalgrowth plate, and exclusion of Twist1 in the mature hy-
pertrophic growth plate chondrocytes.23 Immunohisto-
chemical analyses of murine joints showed nuclear
localization of Twist1 at the articular surface in wild type
adult mice (Fig. 4). Expression of Twist1 proteins was
observed in the superficial zone articular chondrocytes
(Fig. 4e), whereas limited localization of Twist1 in chon-
drocytes was present in the large hypertrophic cells near
the tidemark (Fig. 4f). The expression of Twist1 was not
restricted to cells at the articular surface, as nuclear signal
was also detected within cells in the typically
fibrocartilage-like cells of the menisci (Fig. 4g).
Fig. 4 Expression of Twist1 in murine articular cartilage. Immunohistochemical staining using Twist1-specific antibodies
showed nuclear Twist1 expression within murine articular chondrocytes at the (a) medial tibal plateau and (b) the medial femoral
condyle of adult mice. The expression of Twist1 appeared most prominent within the superficial zone chondrocytes (panel shown in
e), and to a much lesser extent in the deep zone chondrocytes (panel shown in f). Twist1 positive cells were also detected within
the meniscus (c, g) There was a lack of an immune signal in sections without primary antibody incubation (d). T, tibia, F, femur. M,
meniscus.
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cartilage erosion in a surgery-induced model of OA
Based on the association between Twist1 expression and
the mesenchymal-like features of superficial zone articular
chondrocytes, we speculated that elevated levels of Twist1
in cartilage may impact the severity of cartilage degener-
ation in mice following surgery-induced OA. For these
studies, surgical destabilization of the medial meniscus
(DMM)29 was performed using skeletally mature wild type
mice and Twist1 transgenic mice with forced expression of
Twist1 in type II collagen expressing cells and their prog-
eny.23 The DMM knee joints from wild type and Twist1
transgenic mice were imaged by mCT for the presence of
osteophytes. mCT imaging revealed enlarged and exten-
sively ossified medial menisci as well as evidence of
osteophyte formation within the surgical joints of wild type
mice (Fig. 5A). Conversely, mCT imaging of the DMM joints
of Twist1 transgenic mice revealed limited evidence of
osteophyte formation at 12 weeks post-surgery.
We further evaluated the changes that arise following
DMM surgery in both phenotypes by histological evaluation.
Knee joints from the nonsurgical, control limbs from both
genotypes showed a smooth, intact articular surface
(Fig. 5B). In contrast, Alcian blue staining of the medial
compartment of the surgical DMM joints in wild type mice
revealed extensive cartilage erosion marked by the pres-
ence of fissures within the medial compartment following
12 weeks of DMM-induced OA (Fig. 5B). In contrast, trans-
genic mice with sustained Twist1 expression in type II
collagen-expressing cells and their progeny exhibited a
remarkably well-preserved articular cartilage surface in the
surgical DMM joints (Fig. 5). Histologic assessment of the
severity of the OA phenotype within the four quadrants of
joint (medial tibial plateau, lateral tibial plateau, medial
femoral condyle, lateral femoral condyle) using a modified
Chamber’s scoring system revealed that the most signifi-
cant damage occurred within the medial tibial plateau of
the surgical limb in wild type mice. Notably, this semi-
quantitative histological evaluation revealed a less severe
phenotype in the medial tibial plateau of surgical joints
from Twist1 transgenic mice compared to wild type mice at
12 weeks post-surgery. Collectively, these observations
suggest that chondrocyte-specific over-expression of Twist1
may confer a protective effect against the development of
articular cartilage degeneration in a translational OA mu-
rine model.
Discussion
In this study, we examined a previously unexplored role of
Twist1 in human and murine articular cartilage. Our novel
findings revealed that Twist1 exhibits a distinct zonal dis-
tribution in normal human articular cartilage, and that
changes in its distribution arise during human OA patho-
physiology. Enrichment of Twist1 proteins in articular
chondrocytes at the superficial zone in normal articular
cartilage was suggestive of a functional role in the main-
tenance of immature, progenitor-like cells. This was
further supported by our in vitro studies demonstrating the
high levels of Twist1 transcripts in the mesenchymal-likechondrocytes that had undergone de-differentiation and
loss of chondrocyte gene expression. We further deter-
mined the aberrant activation of Twist1 in cartilage cell
clusters and within articular chondrocytes in deep zone
cartilage is associated with human OA. Moreover, our
in vivo studies suggested that the gain of Twist1 function in
murine cartilage could attenuate the severity of cartilage
degeneration at 12 weeks following surgical induction of
OA. Together, these findings highlight a potentially novel
role for this bHLH transcription factor in the preservation of
articular cartilage in vivo.
Human articular cartilage is a highly organized tissue
composed of three distinct layers above the
tidemark w the superficial, middle, and deep zones. Each
of these zone displays unique histologic features as well as
important differences in proteoglycan content, gene
expression profiles, and chondrocyte metabolism.35e37
Genome-wide expression profiling of the superficial, mid-
dle and deep zone of normal human articular cartilage by
Grogan and colleagues showed that the greatest differ-
ences in gene expression occur between the chondrocytes
in the superficial zone and the deep zone.37 The superficial
zone of adult human cartilage contains the highest per-
centage of cells that exhibit phenotypic and functional
properties of mesenchymal-like progenitor cells.35,36,38e41
We speculate that the enrichment of Twist proteins
within the superficial zone chondrocytes shown in our
immunohistochemical analyses may be reflective of the
involvement of Twist1 function in maintaining the imma-
ture differentiation status of chondroprogenitor cells in
adult articular cartilage. In postnatal tissues, Twist1 is
highly expressed in stem cell populations located in
mesoderm-derived mesenchymal tissues, such as muscle,
adipose tissue, and bone marrow, and functions as a regu-
lator of mesenchymal stem cell differentiation.18 Our col-
lective FACS and gene expression analyses demonstrated
that immature, progenitor-like population arising from the
de-differentiation of human articular chondrocyte in vitro
exhibited high levels of Twist1 transcript expression. Twist1
levels were significantly down-regulated as cells turned on
markers of chondrogenic differentiation (Sox9, Col2a1,
Runx2, ColXa1) in response to Bmp-2 induced differentia-
tion in high density cultures. We observed similar down-
regulation of Twist1 transcripts at the early stages of
chondrogenic induction in dedifferentiated human articular
chondrocyte pellet cultures treated with TGFb1 (data not
shown). Our findings are consistent with prior studies
showing the high level of Twist1 expression in murine limb
bud mesenchymal progenitor cells at the onset of chon-
drogenesis.42 A number of studies including ours have
indeed focused on the role of Twist1 as a chondrogenic
repressor.4,19,22,42 Thus, the down-regulation of Twist1
transcripts during chondrogenic differentiation of human
articular chondrocytes are reflective of the known repres-
sive effects of Twist1 activity during chondrogenic differ-
entiation of progenitor cells, chondrocytic cell lines, as
well as growth plate chondrocytes.4,19,22,42,43 Several mo-
lecular mechanisms have been proposed for the repressive
effects of Twist1 on chondrogenic differentiation as a
downstream target of the canonical Wnt, transforming
growth factor (TGF) and Notch signaling pathways,4,19,42 as
well as a negative regulator of Sox9 transactivator function
Fig. 5 Over-expression of Twist1 in articular cartilage confers a protective effect against DMM-induced cartilage degeneration in
mice. (A) uCT analyses of the surgical joints from representative wild type and Twist1 transgenic mice at 12 week post DMM surgery.
(B) Alcian blue staining of sections of knee joints from wild type and Twist1 transgenic (TG) mice at 12 weeks post DMM surgery.
Medial aspect of surgical limbs are shown for two animals of each respective genotype. Arrows demarcate cartilage erosion in wild
type joints at 12 weeks post DMM surgery. Articular surface was well preserved in Twist1 TG mice at 12 weeks post DMM surgery.
Scale bar, 100 mm (C) Histological grading of OA severity in the medial tibial plateau (MTP), lateral tibial plateau (LTP), medial
femoral condyle (MFC), lateral femoral condyle (LFC) from wild type and Twist1 TG mice at 12 weeks post DMM surgery. *p < 0.05.
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98 R.M. Guzzo et al.and expression.21,22 Functional studies using bone marrow-
derived mesenchymal stem cells (MSC) further showed that
populations with high levels of Twist1 expression had a
diminished capacity for osteogenic and chondrogenic dif-
ferentiation in vitro, suggestive of a role as a meditator of
MSC self-renewal.43 Twist1 was shown to inhibit BMP2
signaling and osteogenesis in MC3T3-E1 via the recruitment
of HDAC1 to Smad4, a common component of the BMP and
TGFb signaling pathways involved in the regulation of bone
and cartilage development.44 However, the upstream
mechanisms underlying the suppression of Twist1 expres-
sion and activity during the early stages of chondrogenesis
have not yet been resolved.
Among the hallmark feature of OA include the depletion
of chondrocytes within the superficial zone due to pro-
gressive erosion, and the abnormal activation of differen-
tiation within the deep chondrocytes.45 By semi-
quantitative immunohistochemistry, we determined that
changes in the pattern of Twist1 distribution across the
discrete zones in human articular cartilage occur in OA. A
significant increase in the number of deep zone articular
chondrocytes exhibiting nuclear Twist1 signal was detected
in OA articular cartilage compared to normal cartilage,
indicative of aberrant activation of Twist1 in deep zone
chondrocytes. Moreover, robust Twist1 expression was
found in the nuclei of cartilage cell clusters arising in
response to cell injury in the more severely affected
cartilage specimens. Recent studies have indicated that
such cartilage cell clusters arise adjacent to severe carti-
lage degeneration and exhibit progenitor markers such as
Notch-1, Stro-1, VCAM-1, as well as proliferative poten-
tial.35,46 It remains unclear whether the aberrant activation
of Twist1 in OA cartilage is a component of the remodeling
process that occurs during degeneration or possibly, a
failed attempt to repair the progressive damage to the
articular cartilage during the pathophysiology of the dis-
ease. It is possible that the changes in the zonal distribution
of Twist1 proteins could account, at least in part, for
elevated Twist1 transcript levels detected in human OA
articular cartilage.25
Our in vivo studies suggest that the sustained expression
of Twist1 in type II collagen-expressing cells reducing the
severity of articular cartilage damage and proteoglycan loss
during OA pathophysiology compared with control mice at
12 weeks post-DMM surgery. In human OA cartilage, Twist1
is aberrantly expressed in the deep zone cells, which may
be detrimental to these cells, possibly contributing to
further cartilage degeneration. The Twist transgenic mice
turn on ectopic Twist expression in proliferating chon-
drocytes, thus its expression may aid in chondroprotection
by expanding the progenitor population. Future studies will
be geared towards evaluating the functional consequences
of Twist1 deletion in postnatal cartilage. Specifically, one
needs to address whether lack of Twist1 impairs articular
cartilage homeostasis and/or promotes an accelerated OA
phenotype in mice.Authorship statement
R.M. Guzzo: concept and design, experimental studies,
data analysis, manuscript preparation.F. Alaee: experimental studies.
D. Paglia: experimental studies, data analysis.
J.D. Gibson: experimental studies.
D. Spicer: concept and design, experimental studies,
manuscript editing.
H. Drissi: concept and design, experimental studies,
manuscript editing.Conflicts of interest
All authors have none to declare.Acknowledgments
This work was funded by the State of Connecticut Estab-
lished Investigator Stem Cell Grant (#11SCB08 to HD) and
Stem Cell Seed Grant (#13-SCA-UCHC-11 to RG). The au-
thors are grateful for the donation of normal human
osteochondral tissue from the Musculoskeletal Transplant
Foundation (MTF). We also thank Medtronic for the
generous gift of human recombinant Bmp-2. The authors
further acknowledge Dr. Gregory Polkowski for providing
the human surgical discards used in this study.References
1. Goldring MB, Berenbaum F. Emerging targets in osteoarthritis
therapy. Curr Opin Pharmacol. Apr 9 2015;22:51e63.
2. van der Kraan PM, van den Berg WB. Chondrocyte hypertrophy
and osteoarthritis: role in initiation and progression of carti-
lage degeneration? Osteoarthr Cartil OARS Osteoarthr Res Soc.
Mar 2012;20:223e232.
3. Aigner T, Soder S, Gebhard PM, McAlinden A, Haag J. Mecha-
nisms of disease: role of chondrocytes in the pathogenesis of
osteoarthritisestructure, chaos and senescence. Nat Clin Pract
Rheumatol. Jul 2007;3:391e399.
4. Dong YF, Soung do Y, Chang Y, et al. Transforming growth
factor-beta and Wnt signals regulate chondrocyte differentia-
tion through Twist1 in a stage-specific manner. Mol Endocrinol
Baltim Md. Nov 2007;21:2805e2820.
5. Chen ZF, Behringer RR. Twist is required in head mesenchyme
for cranial neural tube morphogenesis. Genes Dev. Mar 15
1995;9:686e699.
6. Bialek P, Kern B, Yang X, et al. A twist code determines the
onset of osteoblast differentiation. Dev Cell. Mar 2004;6:
423e435.
7. Miraoui H, Marie PJ. Pivotal role of Twist in skeletal biology and
pathology. Gene. Nov 15 2010;468:1e7.
8. Krawchuk D, Weiner SJ, Chen YT, et al. Twist1 activity
thresholds define multiple functions in limb development. Dev
Biol. Nov 2010;347:133e146.
9. Loebel DA, Hor AC, Bildsoe HK, Tam PP. Timed deletion of
twist1 in the limb bud reveals age-specific impacts on autopod
and zeugopod patterning. PloS One. 2014;9:e98945.
10. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of
morphogenesis, plays an essential role in tumor metastasis.
Cell. Jun 25 2004;117:927e939.
11. Puisieux A, Valsesia-Wittmann S, Ansieau S. A Twist for survival
and cancer progression. Br J Cancer. Jan 16 2006;94:13e17.
12. Cheng GZ, Zhang W, Wang LH. Regulation of cancer cell sur-
vival, migration, and invasion by twist: AKT2 comes to inter-
play. Cancer Res. Feb 15 2008;68:957e960.
Aberrant expression of Twist1 in diseased articular cartilage 9913. Li QQ, Xu JD, Wang WJ, et al. Twist1-mediated adriamycin-
induced epithelial-mesenchymal transition relates to multi-
drug resistance and invasive potential in breast cancer cells.
Clin Cancer Res. Apr 15 2009;15:2657e2665.
14. Paznekas WA, Cunningham ML, Howard TD, et al. Genetic
heterogeneity of Saethre-Chotzen syndrome, due to TWIST and
FGFR mutations. Am J Hum Genet. Jun 1998;62:1370e1380.
15. O’Rourke MP, Soo K, Behringer RR, Hui CC, Tam PP. Twist
plays an essential role in FGF and SHH signal transduction
during mouse limb development. Dev Biol. Aug 1 2002;248:
143e156.
16. Zhang Z, Sui P, Dong A, et al. Preaxial polydactyly: interactions
among ETV, TWIST1 and HAND2 control anterior-posterior
patterning of the limb. Dev Camb Engl. Oct 2010;137:
3417e3426.
17. Firulli BA, Redick BA, Conway SJ, Firulli AB. Mutations within
helix I of Twist1 result in distinct limb defects and variation of
DNA binding affinities. J Biol Chem. Sep 14 2007;282:
27536e27546.
18. Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related
biological functions of Twist1 and underlying molecular
mechanisms. Cell Res. Jan 2012;22:90e106.
19. Reinhold MI, Kapadia RM, Liao Z, Naski MC. The Wnt-inducible
transcription factor Twist1 inhibits chondrogenesis. J Biol
Chem. Jan 20 2006;281:1381e1388.
20. Gu S, Reinhold MI, Naski MC. The Wnt target gene Twist1 in-
hibits Sox9, the master regulator of chondrogenesis. In: 30th
Annual Meeting of the American Society of Bone and Mineral
Research. Montreal, Quebec, Canada. 2008.
21. Gu S, Boyer TG, Naski MC. Basic helix-loop-helix transcription
factor Twist1 inhibits transactivator function of master chon-
drogenic regulator Sox9. J Biol Chem. Jun 15 2012;287:
21082e21092.
22. Goodnough LH, Chang AT, Treloar C, Yang J, Scacheri PC,
Atit RP. Twist1 mediates repression of chondrogenesis by beta-
catenin to promote cranial bone progenitor specification. Dev
Camb Engl. Dec 1 2012;139:4428e4438.
23. Guzzo RM, Andreeva V, Spicer DB, Drissi MH. Persistent
expression of Twist1 in chondrocytes causes growth plate ab-
normalities and dwarfism in mice. Int J Dev Biol. 2011;55:
641e647.
24. Hinoi E, Bialek P, Chen YT, et al. Runx2 inhibits chondrocyte
proliferation and hypertrophy through its expression in the
perichondrium. Genes Dev. Nov 1 2006;20:2937e2942.
25. Karlsson C, Dehne T, Lindahl A, et al. Genome-wide expression
profiling reveals new candidate genes associated with osteo-
arthritis. Osteoarthr Cartil OARS Osteoarthr Res Soc. Apr 2010;
18:581e592.
26. Soung do Y, Talebian L, Matheny CJ, et al. Runx1 dose-
dependently regulates endochondral ossification during skel-
etal development and fracture healing. J Bone Miner Res Off J
Am Soc Bone Miner Res. Jul 2012;27:1585e1597.
27. Guzzo RM, Scanlon V, Sanjay A, Xu RH, Drissi H. Establishment
of human cell type-specific iPS cells with enhanced chondro-
genic potential. Stem Cell Rev. 2014;10:820e829. Jun 25.
28. Guzzo RM, Gibson J, Xu RH, Lee FY, Drissi H. Efficient differ-
entiation of human iPSC-derived mesenchymal stem cells to
chondroprogenitor cells. J Cell Biochem. Feb 2013;114:
480e490.
29. Kamekura S, Hoshi K, Shimoaka T, et al. Osteoarthritis devel-
opment in novel experimental mouse models induced by knee
joint instability. Osteoarthr Cartil OARS Osteoarthr Res Soc.
Jul 2005;13:632e641.30. Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The
OARSI histopathology initiative e recommendations for histo-
logical assessments of osteoarthritis in the mouse. Osteoarthr
Cartil OARS Osteoarthr Res Soc. Oct 2010;18(suppl. 3):
S17eS23.
31. Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T, Mainil-
Varlet P. Immunophenotypic analysis of human articular
chondrocytes: changes in surface markers associated with cell
expansion in monolayer culture. J Cell Physiol. Mar 2005;202:
731e742.
32. Diaz-Romero J, Nesic D, Grogan SP, Heini P, Mainil-Varlet P.
Immunophenotypic changes of human articular chondrocytes
during monolayer culture reflect bona fide dedifferentiation
rather than amplification of progenitor cells. J Cell Physiol.
Jan 2008;214:75e83.
33. de la Fuente R, Abad JL, Garcia-Castro J, et al. Dediffer-
entiated adult articular chondrocytes: a population of human
multipotent primitive cells. Exp Cell Res. Jul 15 2004;297:
313e328.
34. Lotz MK, Otsuki S, Grogan SP, Sah R, Terkeltaub R, D’Lima D.
Cartilage cell clusters. Arthritis Rheum. Aug 2010;62:
2206e2218.
35. Grogan SP, Miyaki S, Asahara H, D’Lima DD, Lotz MK. Mesen-
chymal progenitor cell markers in human articular cartilage:
normal distribution and changes in osteoarthritis. Arthritis Res
Ther. 2009;11:R85.
36. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of
mesenchymal progenitor cells in normal and osteoarthritic
human articular cartilage. Arthritis Rheum. May 2004;50:
1522e1532.
37. Grogan SP, Duffy SF, Pauli C, et al. Zone-specific gene
expression patterns in articular cartilage. Arthritis Rheum. Feb
2013;65:418e428.
38. Dowthwaite GP, Bishop JC, Redman SN, et al. The surface of
articular cartilage contains a progenitor cell population. J Cell
Sci. Feb 29 2004;117:889e897.
39. Henson FM, Bowe EA, Davies ME. Promotion of the intrinsic
damage-repair response in articular cartilage by fibroblastic
growth factor-2. Osteoarthr Cartil OARS Osteoarthr Res Soc.
Jun 2005;13:537e544.
40. Hiraoka K, Grogan S, Olee T, Lotz M. Mesenchymal progenitor
cells in adult human articular cartilage. Biorheology. 2006;43:
447e454.
41. Hattori S, Oxford C, Reddi AH. Identification of superficial zone
articular chondrocyte stem/progenitor cells. Biochem Biophys
Res Commun. Jun 22 2007;358:99e103.
42. Tian Y, Xu Y, Fu Q, et al. Notch inhibits chondrogenic differ-
entiation of mesenchymal progenitor cells by targeting Twist1.
Mol Cell Endocrinol. Mar 5 2015;403:30e38.
43. Isenmann S, Arthur A, Zannettino AC, et al. TWIST family of
basic helix-loop-helix transcription factors mediate human
mesenchymal stem cell growth and commitment. Stem Cells
Dayt Ohio. Oct 2009;27:2457e2468.
44. Hayashi M, Nimura K, Kashiwagi K, et al. Comparative roles of
Twist-1 and Id1 in transcriptional regulation by BMP signaling. J
Cell Sci. Apr 15 2007;120:1350e1357.
45. Fukui N, Miyamoto Y, Nakajima M, et al. Zonal gene expression
of chondrocytes in osteoarthritic cartilage. Arthritis Rheum.
Dec 2008;58:3843e3853.
46. Hoshiyama Y, Otsuki S, Oda S, et al. Chondrocyte clusters
adjacent to sites of cartilage degeneration have characteris-
tics of progenitor cells. J Orthop Res Off Publ Orthop Res Soc.
Apr 2015;33:548e555.
